CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The Miiskin project develops an artificial intelligence-based app to assist users in monitoring skin changes for early detection of malignant melanoma. This tool enhances the accuracy of skin assessments and facilitates communication between patients and healthcare providers.
Malignant Melanoma (MM) is a tumour which originates mostly in the skin melanocytes and is responsible for most deaths caused by skin cancer, due to the high risk of lymphatic metastases and expansion to other areas of the body.
Globally, 232,000 people are diagnosed with MM every year, 90,000 of those concentrated in Europe.
While early detection of melanoma has a 98% survival rate, late detection has only a 10-25% survival rate, with a mortality rate going from 3% in countries like Norway or D…
MIISKIN APS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
